Clinical Trials on Hypersensitivity Pneumonitis in New Zealand

Total 1216 results

Weill Medical College of Cornell University
Pulmonary Fibrosis Foundation

Completed

Assessing Health Related Quality of Life in Hypersensitivity Pneumonitis (CHP-HRQOL)

Interstitial Lung Disease | Hypersensitivity Pneumonitis | Extrinsic Allergic Alveolitis | Health-related Quality of Life | Chronic Hypersensitivity Pneumonitis

United States
GlaxoSmithKline

Completed

Spacer Comparison In Adult Asthmatics

Asthma

New Zealand
GlaxoSmithKline

Completed

A Study to Assess the Bronchodilator Effect of a Single Dose of Fluticasone Furoate (FF)/ Vilanterol (VI) 100/25 Micrograms (mcg) Combination When Administered in Adult Patients With Asthma

Asthma

New Zealand
GlaxoSmithKline

Completed

Single Dose GW685698X Magnesium Stearate Study In Asthmatic Patients.

Asthma

New Zealand
GlaxoSmithKline

Completed

This Study Will Examine the Effects of GSK256066 to Protect Mild Steroid-naive Asthmatics Against an Antigen Challenge

Asthma

New Zealand
GlaxoSmithKline

Completed

The Effect Of AVANDIA On The Late Asthmatic Response

Asthma

New Zealand
University of Otago

Completed

Does Improving Insulation and Heating Improve Health?

Asthma

New Zealand
GlaxoSmithKline

Completed

Study on the Effects of an AMP Challenge on Asthmatic Patients Following Treatment With Fluticasone Propionate

Asthma

New Zealand
GlaxoSmithKline

Completed

A Phase IIA FF/VI Study to Measure FeNO in Asthmatic Patients.

Asthma

New Zealand
Resistentia Pharmaceuticals AB

Completed

Safety Study of Anti-IgE Immunotherapy in Allergic Patients

Allergy

New Zealand
Tavotek Biotherapeutics

Recruiting

A Study of TAVO101 in Atopic Dermatitis Patients

Atopic Dermatitis

New Zealand
GlaxoSmithKline

Completed

Study In Airway Physiology In Children SERETIDE DISKUS ® Inhlaer and FLIXOTIDE® Inhaler Are Trademarks of GSK Group of Companies.

Asthma

United Kingdom, New Zealand
AstraZeneca

Completed

A Study in Healthy Volunteers and Patients With Mild Asthma to Investigate the Safety, Anti-inflammatory Effect of Inhaled AZD0449

Asthma

New Zealand, United Kingdom
GlaxoSmithKline

Completed

Pharmacokinetic and Pharmacodynamic (PK and PD) Study of Fluticasone Propionate and Salmeterol Combination Product Delivered in a Capsule-based Inhaler and in a Multi-dose Dry Powder Inhaler in Moderate Asthma Patients and Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients.

Asthma

Australia, New Zealand
GlaxoSmithKline

Completed

Clinical Endpoint Trial Investigating Once Daily and Bronchodilator Dosing

Asthma

New Zealand, South Africa
GlaxoSmithKline

Completed

Randomised Study Comparing the Effects of Inhaled Fluticasone Furoate (FF)/Vilanterol (VI; GW642444M) Combination and FF on an Allergen Induced Asthmatic Response

Asthma

United Kingdom, Germany, New Zealand
GlaxoSmithKline

Completed

Randomised Study Comparing the Effects of Inhaled FF/GW642444M Combination, FF and GW642444M on an Allergen Induced Asthmatic Response

Asthma

Sweden, Australia, New Zealand
Ribon Therapeutics, Inc.

Recruiting

SAD/MAD Safety and PK Study of RBN-3143 in Healthy and Atopic Dermatitis Subjects

Atopic Dermatitis

Australia, New Zealand
Naestved Hospital

Recruiting

Implementation of Evidence-based Breathing Retraining for Patients With Asthma in Region Zealand (EmBRAiZ)

Asthma

Denmark
Merck Sharp & Dohme LLC

Completed

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1029 in Participants With Mild to Moderate Asthma

Asthma

United States, Australia, New Zealand, South Africa
Equillium
Biocon Limited; Equillium AUS Pty Ltd

Completed

A Study of Itolizumab (EQ001) to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity in Uncontrolled Asthma (EQUIP)

Asthma

New Zealand, Australia
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Terminated

Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Steroid-Refractory Pneumonitis

United States
Memorial Sloan Kettering Cancer Center
Boehringer Ingelheim

Completed

Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis

Lung Cancer | Lung Metastases

United States
Intellia Therapeutics

Not yet recruiting

Long-Term Follow-Up (LTFU) of Subjects Treated With NTLA 2002

Hereditary Angioedema

France, New Zealand, United Kingdom
Mundipharma Research Limited

Completed

A Study to Evaluate the Effect of Fluticasone/Formoterol Breath Actuated Inhaler (BAI) or Relvar® Ellipta® DPI on Ventilation Heterogeneity in Asthma

Asthma

United Kingdom, Sweden, Australia, New Zealand, Slovakia
University of Aarhus
Aarhus University Hospital; Westmead and Blacktown Hospital, Sydney West Radiation...

Recruiting

Functional Lung Avoidance SPECT-guided Radiation Therapy of Lung Cancer (ASPECT)

Lung Cancer | Pulmonary Disease | Radiation Pneumonitis | Lung Function Decreased | Radiation-Induced Disorder

Australia, Denmark
Akesobio Australia Pty Ltd

Completed

A Study of AK120 (IL-4Rα) in Healthy Subjects and Subjects With Moderate- to- Severe Atopic Dermatitis

Atopic Dermatitis

New Zealand, Australia
Regeneron Pharmaceuticals
Sanofi

Completed

Safety and Tolerability of Dupilumab in Participants With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis

Germany, New Zealand, Australia
Allergan

Completed

Efficacy and Safety Study of Cyclosporine 0.010% to Treat Atopic Keratoconjunctivitis

Atopic Conjunctivitis

Canada, Czech Republic, United States, Italy, Israel, New Zealand, Spain, India, Germany, Australia, France, United Kingdom
Intellia Therapeutics

Active, not recruiting

NTLA-2002 in Adults With Hereditary Angioedema (HAE) (NTLA-2002)

Hereditary Angioedema

France, New Zealand, Germany, United Kingdom, Netherlands, Australia
Reata, a wholly owned subsidiary of Biogen

Completed

Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT

Idiopathic Pulmonary Fibrosis | Pulmonary Arterial Hypertension | Pulmonary Hypertension | Interstitial Lung Disease | Sarcoidosis | Idiopathic Interstitial Pneumonia | Cryptogenic Organizing Pneumonia | Desquamative Interstitial Pneumonia | Respiratory Bronchiolitis Associated Interstitial Lung Disease and other conditions

United States, Germany
John Hunter Children's Hospital
Thrasher Research Fund; Aerocrine AB; University of Newcastle, Australia; Hunter... and other collaborators

Completed

PEAnut Anaphylaxis Predictors (PEAAP)

Peanut Hypersensitivity | Anaphylaxis

Australia
National Institute of Allergy and Infectious Diseases...

Completed

An Interventional Study of Milk Allergy

Milk Hypersensitivity | Food Hypersensitivity

United States
Weill Medical College of Cornell University

Completed

Reduction of Peanut Reactivity and Immune Modulation With Anti-IgE Therapy

Peanut Allergy

United States
National Institute of Allergy and Infectious Diseases...
Asthma and Allergic Diseases Cooperative Research Centers

Completed

Study of Milk Allergy and Tolerance in Children

Milk Hypersensitivity | Food Hypersensitivity

United States
Scott Sicherer
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Immune and Clinical Implications of Threshold-based Phenotypes of Peanut Allergy (CAFETERIA)

Peanut Allergy | Food Allergy

United States
Allertein Therapeutics, LLC
Consortium of Food Allergy Research

Completed

Peanut Allergy Vaccine Study in Healthy and Peanut-allergic Adults

Hypersensitivity | Food Hypersensitivity | Peanut Hypersensitivity | Immediate Hypersensitivity

United States
National Institute of Allergy and Infectious Diseases...
Consortium of Food Allergy Research

Terminated

Impact of Vaccination on Th2 Immunity in Infancy

Food Hypersensitivity

United States
Intrommune Therapeutics

Completed

OMEGA Study: A Study of the Safety and Feasibility of Up-titration With INT301 in Adults With Sensitivity to Peanut

Peanut Allergy

United States
Johns Hopkins University
Icahn School of Medicine at Mount Sinai

Terminated

The Safety and Efficacy of a Peanut Immunotherapy Dissolving Film for Peanut Allergy

Peanut Allergy

United States
Icahn School of Medicine at Mount Sinai

Recruiting

JAK Inhibition in Food Allergy

Food Allergy

United States
Icahn School of Medicine at Mount Sinai
Fordham University

Completed

Self-injection and Self-management

Food Allergy

United States
Icahn School of Medicine at Mount Sinai
Société des Produits Nestlé (SPN)

Completed

Partially Hydrolyzed Whey Formula in Cow's Milk Allergic Patients

Food Allergy

United States
University of Rochester
National Institute of Allergy and Infectious Diseases (NIAID)

Not yet recruiting

Expecting Mother's Study of Consumption or Avoidance of Peanut and Egg (ESCAPE)

Egg Allergy | Food Allergy Peanut | Food Allergy in Infants | Allergy and Immunology | Peanut and Nut Allergy

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Terminated

Nintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery and Are Undergoing Chemoradiation Therapy

Lung Non-Squamous Non-Small Cell Carcinoma | Stage II Lung Non-Small Cell Cancer AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IV... and other conditions

United States
Northwell Health
Masimo Corporation

Completed

Pleth Variability and Asthma Severity in Children

Status Asthmaticus

United States
AstraZeneca

Terminated

Mobile Devices to Detect Early Pneumonitis in Stage III NSCLC Patients on Durvalumab. (ON TRAX)

Unresectable Stage III NSCLC

United States
Hugh A Sampson, MD
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

OIT and Xolair® (Omalizumab) in Cow's Milk Allergy

Milk Allergy

United States
Icahn School of Medicine at Mount Sinai

Completed

Anxiety About Casual Exposure to Food Allergens (TOUCH)

Food Allergy

United States
Xiu-Min Li

Unknown

E-B-FAHF-2, Multi OIT and Xolair (Omalizumab) for Food Allergy

Food Allergy

United States

Clinical Trials on Hypersensitivity Pneumonitis in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations